As Expected, Quest Diagnostics Posts 2 Percent Sales Decline | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics today reported that its third quarter sales were down 2 percent year over year, in line with its pre-announcement made just last week.

The clinical lab and diagnostic information services provider reported revenues of $1.79 billion for the three months ended Sept. 30, down 2 percent year over year from $1.82 billion. Analysts had previously expected $1.84 billion in revenues for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.